Wednesday, November 9, 2016

Can TAVR Cost Be Justified in Mid-Risk Patients?

(MedPage Today) -- Value hinges on survival benefit, much shorter admissions
via Can TAVR Cost Be Justified in Mid-Risk Patients?
by

No comments:

Post a Comment